| Business Summary | | Imaging
Diagnostic
Systems,
Inc.
is
a
development
stage
medical
technology
company.
Since
its
inception,
the
Company
has
been
engaged
in
the
development
and
testing
of
a
Computed
Tomography
Laser
Mammography
device
for
detecting
breast
cancer
through
the
skin
in
a
non-invasive
procedure
(CTLM).
The
CTLM
employs
a
proprietary
laser
and
proprietary
scanning
geometry
and
reconstruction
algorithms
to
detect
and
analyze
tissue
in
the
breast
for
indicia
of
malignancy
or
benignancy.
The
components
of
the
laser
system
are
purchased
from
two
unaffiliated
parties
and
assembled
and
installed
by
the
Company
into
the
CTLM.
The
Company
is
also
investigating
the
use
of
fluorescent
and
PDT
compounds
in
conjunction
with
the
CTLM
for
detection
of
breast
abnormalities. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Imaging
Diagnostic
Systems,
a
medical
technology
Co.,
has
developed
and
is
testing
a
Computed
Tomograph
Laser
Mammography
for
detecting
breast
cancer
through
the
skin
in
a
non-invasive
procedure.
For
the
nine
months
ended
3/31/01,
the
Company
reported
no
revenues.
Net
loss
applicable
to
Common
rose
40%
to
$5.5
million.
Higher
loss
reflects
increased
preferred
dividends,
the
addition
of
personnel,
and
increased
loan
placement
expenses
and
fees. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Linda Grable, 62 Chairman,
CEO | $119K | John D'Auguste Pres | -- | Ed Horton COO | -- | Allan Schwartz, 58 Exec.
VP, CFO | 119K | Arno Pantalone VP
of Global Sales and Marketing | -- | Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|